Tenderwize
Retour à la recherche

Open house Arzneimittelrabattverträge Nitisinon, ATC A16AX04

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline May 03, 2028 · 613 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Nitisinon, ATC A16AX04

65/100

Score d'opportunité

PromisingLow complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

65 / 100

Complexité

20 / 100

Facteurs de risque

The notice explicitly states this is NOT a procurement procedure under EU law; it's an open-house model under social la...

No volume or value commitment from buyer; discounts must be offered without guaranteed sales. The contract may be termi...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Strong opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jun 2028
  • Non-exclusive discount agreements for Nitisinon (ATC A16AX04) with AOK Bayern.
  • All eligible pharmaceutical companies join on identical terms; no selection or competition.
Afficher le résumé complet

This is an open-house model (not a traditional procurement) for non-exclusive discount agreements on the active substance Nitisinon (ATC A16AX04) with AOK Bayern. All interested pharmaceutical companies meeting eligibility can join. Contracts run from 01.07.2026 to 30.06.2028, with possible later start dates until 03.05.2028. No award criteria apply; only a signed self-declaration of reliability is required. No estimated value provided. Submission can be in paper (two originals) or electronically with qualified electronic signature. Documents must be in German.

Risques

The notice explicitly states this is NOT a procurement procedure under EU law; it's an open-house model under social la...

No volume or value commitment from buyer; discounts must be offered without guaranteed sales. The contract may be termi...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Eligibility

  • Only pharmaceutical companies are eligible.

Administrative

  • Submit signed self-declaration of reliability (downloadable from portal).
  • Submit signed contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.

Acheteur

Localisation

München, DEU

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Nitisinon, ATC A16AX04

Non-exclusive discount agreements for Nitisinon (ATC A16AX04) with AOK Bayern. All eligible pharmaceutical companies can join on identical terms. Contract duration 24 months from earliest start 01.07.2026 to 30.06.2028. Continuous enrollment possible until 03.05.2028.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Jun 2026 - Jun 2028

Catégorie

Pharmaceutical products

Date limite

Deadline May 03, 2028

Détails de la procédure

Date de publication
17 May 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
339253-2026

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30